Landmark Finding that Showed Brains of Kids with ADHD Mature Later Was Actually a Mirage in the Data, New Research Finds

Why It Matters

The correction undermines a widely cited biological marker for ADHD, highlighting the need for more robust, sex‑aware neuroscience methods and tempering expectations for brain‑based diagnostics.

Key Takeaways

• Original ADHD brain study used 223 participants per group
• New ABCD replication used over 11,000 children
• Accounting for sex differences eliminated cortical thickness link to ADHD
• Findings highlight replication challenges in neuroscience
• No reliable brain‑based biomarker for ADHD identified yet

Pulse Analysis

The 2008 National Institute of Mental Health study that linked delayed cortical thinning to ADHD quickly became a cornerstone of neurodevelopmental research. By imaging 223 children with ADHD and a matched control group, the investigators reported a lag in cortical maturation that seemed to mirror the behavioral immaturity of the disorder. The study’s influence extended beyond academia, shaping clinical narratives and fueling hopes for imaging‑based diagnostics.

A decade‑plus later, researchers led by Matthew Albaugh leveraged the Adolescent Brain Cognitive Development (ABCD) study, the largest longitudinal neuroimaging cohort in the United States, to revisit the claim. With more than 11,000 nine‑ and ten‑year‑olds tracked over ten years, the team could model cortical thickness trajectories while explicitly controlling for sex differences. When boys’ slower thinning rates were separated from girls’, the previously observed association between attention problems and cortical thickness vanished, indicating the original effect was a mirage created by an unbalanced sex distribution in smaller samples.

The implications reverberate through both ADHD science and the broader field of neuroscience. The episode underscores how early, high‑impact findings can persist despite methodological blind spots, contributing to the ongoing replication crisis. It also signals that sex must be treated as a fundamental variable rather than a post‑hoc adjustment. While ADHD remains a biologically rooted condition, the search for reliable brain‑based biomarkers must adopt larger, more diverse datasets and nuanced analytic frameworks to avoid false leads and to ultimately inform personalized treatment strategies.